Scalability of the strategic model and focus on execution support the 2025 ambitions:
- Revenue: average annual growth of 10%
- EBITDA adj margin growing annually between +40/+70 basis points, to exceed 20%
- Annual Recurring Cash conversion rate heigher than 60%
- Main ESG projects announced
Nerio Alessandri, Founder and CEO, comments: “Since the IPO we have promised our shareholders profitable and sustainable long-term growth and we have respected this commitment, despite a very changed international context. We have continued to invest in skills and research, even in the difficult years of Covid and we will continue to do so because the wellness lifestyle is proving to be the most sustainable medicine for people and, consequently, for companies and governments.
Today we share Technogym's dream and the path to fulfilling it: Technogym is the new medicine.
Some particularly forward-looking countries have already activated the medical prescription of physical exercise as a real cure for many pathologies, in line with the 'Exercise is Medicine' program, launched by Technogym over 15 years ago. It is a win-win system for the patient and for the healthcare system which will involve many more countries in the medium term. Those more advanced in this process have involved us as their wellness advisor to embark on a virtuous path, in balance between physical exercise, nutrition and mental approach.
Our vision and strategy lead us to always put people's needs at the centre, as evidenced by some of our ESG projects announced today, since a healthier world is certainly a better and more sustainable world.
We continue every day to contribute to people's well-being, looking to the future with renewed optimism: let's move for a better world".
